|
|||||
|
|
Population pharmacokinetic modeling of PF-06439535 (a bevacizumab biosimilar) and reference bevacizumab (Avastin®) in patients with advanced non-squamous non-small cell lung cancer |
|
| Authors: | Li Cheryl S. W. Sweeney Kevin Cronenberger Carol |
| Abstract: | Cancer Chemotherapy and Pharmacology - The objectives of this analysis were to characterize the population pharmacokinetics (PK) of PF-06439535 (a bevacizumab biosimilar) and reference bevacizumab... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |